TABLE: 2014 IPO values mixed at mid-year
This article was originally published in Scrip
Executive Summary
Going public isn't easy, even in a market that's receptive to biotechnology initial public offerings, but 41 drug developers made the leap in the US during the first half of 2014 and raised $2.6bn.